nodes	percent_of_prediction	percent_of_DWPC	metapath
Methoxamine—ADRA1A—hindbrain—autistic disorder	0.0227	0.101	CbGeAlD
Methoxamine—ADRA1D—forebrain—autistic disorder	0.0219	0.0973	CbGeAlD
Methoxamine—ADRA1D—telencephalon—autistic disorder	0.0201	0.0895	CbGeAlD
Methoxamine—ADRA1A—brainstem—autistic disorder	0.013	0.0579	CbGeAlD
Methoxamine—ADRA1B—head—autistic disorder	0.0128	0.0569	CbGeAlD
Methoxamine—ADRA1A—forebrain—autistic disorder	0.0126	0.0559	CbGeAlD
Methoxamine—ADRA1D—head—autistic disorder	0.0125	0.0557	CbGeAlD
Methoxamine—ADRA1B—nervous system—autistic disorder	0.0121	0.054	CbGeAlD
Methoxamine—ADRA1D—nervous system—autistic disorder	0.0119	0.0528	CbGeAlD
Methoxamine—ADRA1B—central nervous system—autistic disorder	0.0117	0.052	CbGeAlD
Methoxamine—ADRA1A—telencephalon—autistic disorder	0.0115	0.0514	CbGeAlD
Methoxamine—ADRA1D—central nervous system—autistic disorder	0.0114	0.0508	CbGeAlD
Methoxamine—ADRA1B—brain—autistic disorder	0.00928	0.0413	CbGeAlD
Methoxamine—ADRA1D—brain—autistic disorder	0.00907	0.0404	CbGeAlD
Methoxamine—ADRA1A—head—autistic disorder	0.00719	0.032	CbGeAlD
Methoxamine—ADRA1A—nervous system—autistic disorder	0.00682	0.0303	CbGeAlD
Methoxamine—ADRA1A—central nervous system—autistic disorder	0.00656	0.0292	CbGeAlD
Methoxamine—ADRA1A—cerebellum—autistic disorder	0.00642	0.0285	CbGeAlD
Methoxamine—ADRA1A—brain—autistic disorder	0.00521	0.0232	CbGeAlD
Methoxamine—ADRA1D—Signaling Pathways—PRLR—autistic disorder	0.000507	0.000654	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—OPRM1—autistic disorder	0.000505	0.000651	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—OXTR—autistic disorder	0.000503	0.000649	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—DRD1—autistic disorder	0.000502	0.000648	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR ligand binding—HTR2A—autistic disorder	0.000498	0.000642	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—SCT—autistic disorder	0.000498	0.000642	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—OPRM1—autistic disorder	0.000494	0.000637	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—HTR1B—autistic disorder	0.000494	0.000637	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—OXT—autistic disorder	0.000494	0.000637	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—GABBR2—autistic disorder	0.00049	0.000632	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—GRM8—autistic disorder	0.000489	0.000631	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—DRD3—autistic disorder	0.000486	0.000627	CbGpPWpGaD
Methoxamine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—autistic disorder	0.000481	0.00062	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR ligand binding—POMC—autistic disorder	0.000479	0.000618	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—IL5—autistic disorder	0.000476	0.000614	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—GABBR1—autistic disorder	0.000475	0.000613	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—ADM—autistic disorder	0.000475	0.000613	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—WNT2—autistic disorder	0.000474	0.000612	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—CALCA—autistic disorder	0.00047	0.000606	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—GHR—autistic disorder	0.000467	0.000602	CbGpPWpGaD
Methoxamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—autistic disorder	0.000464	0.000599	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—PDE4B—autistic disorder	0.000463	0.000597	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—PDE4A—autistic disorder	0.00046	0.000594	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—DRD1—autistic disorder	0.000459	0.000592	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—OPRM1—autistic disorder	0.000448	0.000578	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—HTR1B—autistic disorder	0.000448	0.000578	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—OXT—autistic disorder	0.000448	0.000578	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—DRD3—autistic disorder	0.000444	0.000573	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR ligand binding—HTR2A—autistic disorder	0.000442	0.000571	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—HTR1B—autistic disorder	0.000438	0.000566	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—OXT—autistic disorder	0.000438	0.000566	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—HTR1D—autistic disorder	0.000437	0.000564	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—GABBR2—autistic disorder	0.000436	0.000562	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—IL5—autistic disorder	0.000435	0.000561	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—ADRB2—autistic disorder	0.000434	0.00056	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—AVPR1A—autistic disorder	0.000431	0.000556	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—CALCA—autistic disorder	0.00043	0.000554	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—PRLR—autistic disorder	0.000421	0.000543	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—DRD1—autistic disorder	0.000417	0.000537	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—GRM5—autistic disorder	0.000416	0.000537	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—VIP—autistic disorder	0.000416	0.000537	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—AVP—autistic disorder	0.000408	0.000526	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—DRD1—autistic disorder	0.000408	0.000526	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—GRM8—autistic disorder	0.000406	0.000524	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—DRD3—autistic disorder	0.000404	0.000521	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—OXTR—autistic disorder	0.000403	0.00052	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—SCT—autistic disorder	0.000399	0.000515	CbGpPWpGaD
Methoxamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—autistic disorder	0.000399	0.000515	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—HTR1B—autistic disorder	0.000398	0.000514	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—OXT—autistic disorder	0.000398	0.000514	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR ligand binding—POMC—autistic disorder	0.000398	0.000513	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—IL5—autistic disorder	0.000395	0.00051	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—DRD3—autistic disorder	0.000395	0.000509	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—ADRB2—autistic disorder	0.000394	0.000508	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—WNT2—autistic disorder	0.000393	0.000508	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—CALCA—autistic disorder	0.00039	0.000503	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—HTR1D—autistic disorder	0.000388	0.000501	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—GHR—autistic disorder	0.000388	0.0005	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—IL5—autistic disorder	0.000386	0.000498	CbGpPWpGaD
Methoxamine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—autistic disorder	0.000386	0.000498	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—PDE4A—autistic disorder	0.000382	0.000493	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—CALCA—autistic disorder	0.000382	0.000492	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—GABBR1—autistic disorder	0.000381	0.000491	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—ADM—autistic disorder	0.000381	0.000491	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—EIF4E—autistic disorder	0.000374	0.000483	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PRLR—autistic disorder	0.000374	0.000482	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—PDE4B—autistic disorder	0.000371	0.000479	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—AVP—autistic disorder	0.00037	0.000477	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—DRD1—autistic disorder	0.00037	0.000477	CbGpPWpGaD
Methoxamine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—autistic disorder	0.000369	0.000476	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—GRM8—autistic disorder	0.000361	0.000466	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—ADRB2—autistic disorder	0.00036	0.000464	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—OPRM1—autistic disorder	0.000359	0.000463	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—DRD3—autistic disorder	0.000358	0.000462	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—AVPR1A—autistic disorder	0.000358	0.000461	CbGpPWpGaD
Methoxamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—autistic disorder	0.000354	0.000457	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR ligand binding—POMC—autistic disorder	0.000353	0.000456	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—IL5—autistic disorder	0.000351	0.000453	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—WNT2—autistic disorder	0.00035	0.000451	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—PLA2G4A—autistic disorder	0.000348	0.000449	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—CALCA—autistic disorder	0.000347	0.000447	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—VIP—autistic disorder	0.000345	0.000446	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—GRM5—autistic disorder	0.000345	0.000446	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—GHR—autistic disorder	0.000344	0.000444	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PDE4A—autistic disorder	0.000339	0.000438	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—HTR2A—autistic disorder	0.000339	0.000437	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—AVP—autistic disorder	0.000338	0.000436	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—OXTR—autistic disorder	0.000335	0.000432	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—SCT—autistic disorder	0.000331	0.000427	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—GZMB—autistic disorder	0.000329	0.000424	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—ADRB2—autistic disorder	0.000327	0.000422	CbGpPWpGaD
Methoxamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—autistic disorder	0.00032	0.000413	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—ADRB2—autistic disorder	0.00032	0.000413	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—HTR1B—autistic disorder	0.000319	0.000411	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—OXT—autistic disorder	0.000319	0.000411	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—AVPR1A—autistic disorder	0.000318	0.00041	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—GABBR1—autistic disorder	0.000316	0.000408	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—ADM—autistic disorder	0.000316	0.000408	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—EIF4E—autistic disorder	0.000311	0.000401	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—HTR2A—autistic disorder	0.000308	0.000397	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—PDE4B—autistic disorder	0.000308	0.000397	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—AVP—autistic disorder	0.000307	0.000396	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—GRM5—autistic disorder	0.000307	0.000396	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—VIP—autistic disorder	0.000307	0.000396	CbGpPWpGaD
Methoxamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—autistic disorder	0.000307	0.000395	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—AVP—autistic disorder	0.0003	0.000388	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—OPRM1—autistic disorder	0.000298	0.000385	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—PRKCB—autistic disorder	0.000297	0.000384	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—OXTR—autistic disorder	0.000297	0.000383	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—TSC1—autistic disorder	0.000297	0.000383	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—DRD1—autistic disorder	0.000297	0.000383	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—SCT—autistic disorder	0.000294	0.000379	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—ADRB2—autistic disorder	0.00029	0.000375	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—PLA2G4A—autistic disorder	0.000289	0.000373	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—NTRK2—autistic disorder	0.000288	0.000372	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—DRD3—autistic disorder	0.000287	0.00037	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—PIK3CG—autistic disorder	0.000285	0.000367	CbGpPWpGaD
Methoxamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—autistic disorder	0.000284	0.000367	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—HTR2A—autistic disorder	0.000281	0.000363	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—IL5—autistic disorder	0.000281	0.000363	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—GABBR1—autistic disorder	0.000281	0.000362	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—ADM—autistic disorder	0.000281	0.000362	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—CALCA—autistic disorder	0.000278	0.000358	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—EIF4E—autistic disorder	0.000276	0.000356	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PDE4B—autistic disorder	0.000273	0.000353	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—AVP—autistic disorder	0.000273	0.000352	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—GZMB—autistic disorder	0.000273	0.000352	CbGpPWpGaD
Methoxamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—autistic disorder	0.000272	0.000351	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—POMC—autistic disorder	0.000271	0.000349	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—PRKCB—autistic disorder	0.00027	0.000348	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—OPRM1—autistic disorder	0.000265	0.000342	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—OXT—autistic disorder	0.000265	0.000342	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—HTR1B—autistic disorder	0.000265	0.000342	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—PIK3CG—autistic disorder	0.000258	0.000333	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—PLA2G4A—autistic disorder	0.000257	0.000331	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—HTR2A—autistic disorder	0.000256	0.00033	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—HTR2A—autistic disorder	0.00025	0.000323	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—PRKCB—autistic disorder	0.000247	0.000318	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—TSC1—autistic disorder	0.000246	0.000318	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—DRD1—autistic disorder	0.000246	0.000318	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—POMC—autistic disorder	0.000246	0.000317	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—PRL—autistic disorder	0.000245	0.000316	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—GZMB—autistic disorder	0.000242	0.000312	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—NTRK2—autistic disorder	0.000239	0.000309	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—DRD3—autistic disorder	0.000238	0.000308	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—PIK3CG—autistic disorder	0.000236	0.000305	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—HTR1B—autistic disorder	0.000235	0.000303	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—OXT—autistic disorder	0.000235	0.000303	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—IL5—autistic disorder	0.000233	0.000301	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—ADRB2—autistic disorder	0.000233	0.0003	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—CALCA—autistic disorder	0.00023	0.000297	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—HTR2A—autistic disorder	0.000227	0.000293	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—POMC—autistic disorder	0.000225	0.00029	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—PRKCB—autistic disorder	0.000224	0.000289	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—PRKCB—autistic disorder	0.000219	0.000283	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—AVP—autistic disorder	0.000219	0.000282	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—TSC1—autistic disorder	0.000219	0.000282	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—DRD1—autistic disorder	0.000219	0.000282	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—IGF2—autistic disorder	0.000218	0.000281	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—PIK3CG—autistic disorder	0.000214	0.000277	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—NTRK2—autistic disorder	0.000213	0.000274	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—DRD3—autistic disorder	0.000212	0.000273	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—PIK3CG—autistic disorder	0.00021	0.000271	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—IL5—autistic disorder	0.000207	0.000267	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—PLA2G4A—autistic disorder	0.000206	0.000265	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—CALCA—autistic disorder	0.000205	0.000264	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—POMC—autistic disorder	0.000204	0.000263	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—PRL—autistic disorder	0.000204	0.000263	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—IL2—autistic disorder	0.0002	0.000258	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—MEF2C—autistic disorder	0.0002	0.000258	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—POMC—autistic disorder	0.0002	0.000258	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—PRKCB—autistic disorder	0.000199	0.000257	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—ITGB3—autistic disorder	0.000195	0.000251	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—ADRB2—autistic disorder	0.000193	0.000249	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—PIK3CG—autistic disorder	0.00019	0.000246	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—HTR2A—autistic disorder	0.000182	0.000235	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—IL2—autistic disorder	0.000182	0.000235	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—AVP—autistic disorder	0.000181	0.000234	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—POMC—autistic disorder	0.000181	0.000234	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PRL—autistic disorder	0.000181	0.000233	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—IGF2—autistic disorder	0.000181	0.000233	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—TSC2—autistic disorder	0.000173	0.000223	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—ADRB2—autistic disorder	0.000172	0.000221	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—PLA2G4A—autistic disorder	0.000171	0.00022	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—APOE—autistic disorder	0.000169	0.000218	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—LEP—autistic disorder	0.000169	0.000218	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—IL2—autistic disorder	0.000166	0.000214	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—MEF2C—autistic disorder	0.000166	0.000214	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—ITGB3—autistic disorder	0.000162	0.000209	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—AVP—autistic disorder	0.000161	0.000208	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—IGF2—autistic disorder	0.00016	0.000207	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—PRKCB—autistic disorder	0.000159	0.000206	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—PIK3CG—autistic disorder	0.000153	0.000197	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—APC—autistic disorder	0.000153	0.000197	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PLA2G4A—autistic disorder	0.000152	0.000195	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—HTR2A—autistic disorder	0.000151	0.000195	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—IL2—autistic disorder	0.000151	0.000195	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—EGF—autistic disorder	0.000151	0.000195	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—IL2—autistic disorder	0.000148	0.00019	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—MEF2C—autistic disorder	0.000147	0.00019	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—POMC—autistic disorder	0.000145	0.000187	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—ITGB3—autistic disorder	0.000144	0.000185	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—TSC2—autistic disorder	0.000143	0.000185	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—APOE—autistic disorder	0.00014	0.000181	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—LEP—autistic disorder	0.00014	0.000181	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—IGF1—autistic disorder	0.00014	0.00018	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—MAPK1—autistic disorder	0.000139	0.000179	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—HTR2A—autistic disorder	0.000134	0.000173	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—IL2—autistic disorder	0.000134	0.000173	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—SERPINE1—autistic disorder	0.000133	0.000171	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—PRKCB—autistic disorder	0.000132	0.000171	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—TSC2—autistic disorder	0.000127	0.000164	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—PIK3CG—autistic disorder	0.000127	0.000163	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—APC—autistic disorder	0.000127	0.000163	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—EGF—autistic disorder	0.000125	0.000162	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—APOE—autistic disorder	0.000125	0.000161	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—LEP—autistic disorder	0.000125	0.000161	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—POMC—autistic disorder	0.000121	0.000156	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PRKCB—autistic disorder	0.000118	0.000152	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—IGF1—autistic disorder	0.000116	0.00015	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—MAPK1—autistic disorder	0.000115	0.000149	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PIK3CG—autistic disorder	0.000113	0.000145	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—APC—autistic disorder	0.000113	0.000145	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—HRAS—autistic disorder	0.000112	0.000144	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—EGF—autistic disorder	0.000111	0.000143	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—SERPINE1—autistic disorder	0.00011	0.000142	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—IL2—autistic disorder	0.000107	0.000139	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—POMC—autistic disorder	0.000107	0.000138	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—IL6—autistic disorder	0.000107	0.000138	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—IGF1—autistic disorder	0.000103	0.000133	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—MAPK1—autistic disorder	0.000103	0.000132	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—PTEN—autistic disorder	0.000101	0.00013	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—SERPINE1—autistic disorder	9.78e-05	0.000126	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—HRAS—autistic disorder	9.27e-05	0.00012	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—IL2—autistic disorder	8.92e-05	0.000115	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—IL6—autistic disorder	8.87e-05	0.000114	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—PTEN—autistic disorder	8.39e-05	0.000108	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—HRAS—autistic disorder	8.23e-05	0.000106	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—MAPK1—autistic disorder	8.22e-05	0.000106	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—IL2—autistic disorder	7.92e-05	0.000102	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—IL6—autistic disorder	7.88e-05	0.000102	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PTEN—autistic disorder	7.45e-05	9.61e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—MAPK1—autistic disorder	6.82e-05	8.8e-05	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—HRAS—autistic disorder	6.6e-05	8.51e-05	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—IL6—autistic disorder	6.31e-05	8.14e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—MAPK1—autistic disorder	6.06e-05	7.81e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—HRAS—autistic disorder	5.48e-05	7.06e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—IL6—autistic disorder	5.24e-05	6.76e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—HRAS—autistic disorder	4.86e-05	6.27e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—IL6—autistic disorder	4.65e-05	6e-05	CbGpPWpGaD
